These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1224930)

  • 1. [Non-steroidal antirheumatic therapy and the liver].
    Frank O
    Acta Med Austriaca; 1975; 2(4):145-8. PubMed ID: 1224930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylbutazone and hepatitis.
    Fowler PD; Woolf D; Alexander S
    Rheumatol Rehabil; 1975 May; 14(2):71-5. PubMed ID: 1145012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholestasis due to therapy of rheumatoid arthritis.
    Schenker S; Olson KN; Dunn D; Breen KJ; Combes B
    Gastroenterology; 1973 Apr; 64(4):622-9. PubMed ID: 4633722
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and phenylbutazone in rheumatoid arthritis.
    Nyfos L
    Scand J Rheumatol Suppl; 1979; (24):5-7. PubMed ID: 373085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic and renal tolerance of a new preparation of phenylbutazone in rheumatic therapy].
    Carrozzo M; Loizzi P
    Policlinico Med; 1971; 78(2):91-9. PubMed ID: 5564824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver enzymology and antirheumatic medication].
    González Vilchez J; Wamba Aguirre M
    Rev Clin Esp; 1976 Jun; 141(6):559-64. PubMed ID: 968091
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes.
    Nijhawan R; Wierzbicki AS; Tozer R; Lascelles PT; Patsalos PN
    Int J Clin Pharmacol Res; 1990; 10(6):319-23. PubMed ID: 1983078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method].
    Brooks PM; Walker JJ; Lee P; Bell AM; Buchanan WW; Fowler PD; Anderson JA
    Z Rheumatol; 1975; 34(9-10):350-65. PubMed ID: 1106038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diftalone: a new non-steroidal anti-inflammatory agent: comparative study with phenylbutazone in the treatment of rheumatoid arthritis.
    Chalem F; Farias P; Lizarazo H; Peña P
    J Int Med Res; 1977; 5(1):18-25. PubMed ID: 320061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid arthritis: comparison of treatment with monophenylbutazone and phenylbutazone.
    Woodbury JF; Turner WA; Tiongson R
    Can Med Assoc J; 1969 Dec; 101(13):69-71. PubMed ID: 4903691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematotoxic lesions caused by non-steroidal antirheumatic agents].
    Stobbe H; Hüge W
    Z Gesamte Inn Med; 1980 Dec; 35(23):165-9. PubMed ID: 7467611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoid granulomas associated with phenylbutazone treatment.
    Lebacq EG; Desmet V
    Mt Sinai J Med; 1977; 44(6):778-81. PubMed ID: 145540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatic cholestasis due to benetazone].
    Krtek V; Chlumský J
    Vnitr Lek; 1979 Feb; 25(2):152-4. PubMed ID: 570757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kidney findings in polyarthritis under antirheumatic therapy].
    Otto H
    Z Urol Nephrol; 1970 May; 63(5):333-41. PubMed ID: 5513128
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal hepatitis due to phenylbutazone in a child.
    Dhatt PS; Singh H; Gupta HL; Arya RK
    Indian J Pediatr; 1973 Aug; 40(307):293-4. PubMed ID: 4769816
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of effects of drug therapy in chronic rheumatoid arthritis--problems in determination of therapeutic effects of anti-rheumatoid drugs].
    Sugiyama T
    Naika; 1970; 25(5):896-906. PubMed ID: 4914391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxic cholestatic hepatitis secondary to chrysotherapy].
    Frigerio G; Terruzzi V; Butti GC; Minoli G; Rossini A
    Minerva Med; 1981 Jul; 72(29):1941-4. PubMed ID: 7254640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases.
    Ishak KG; Kirchner JP; Dhar JK
    Am J Dig Dis; 1977 Jul; 22(7):611-7. PubMed ID: 879127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic hepatitis following phenylbutazone therapy.
    Muscat-Baron JM; Freeman DM
    Br J Clin Pract; 1966 Aug; 20(8):437-9. PubMed ID: 5944035
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature.
    Benjamin SB; Ishak KG; Zimmerman HJ; Grushka A
    Hepatology; 1981; 1(3):255-63. PubMed ID: 7286906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.